Sell 1/31/2025Downgrade
Bio Essence Corporation (BIOE) was downgraded to E+ from D- on 1/31/2025 due to a substantial decline in the total return index, volatility index and growth index. Earnings per share declined from -$0.0057 to -$0.0316.

Sell 7/24/2024Upgraded
Bio Essence Corporation (BIOE) was upgraded to D- from E+ on 7/24/2024 due to an increase in the volatility index and total return index.

Sell 7/9/2024Downgrade
Bio Essence Corporation (BIOE) was downgraded to E+ from D- on 7/9/2024 due to a decline in the valuation index and volatility index.

Sell 6/20/2024Upgraded
Bio Essence Corporation (BIOE) was upgraded to D- from E+ on 6/20/2024 due to an increase in the volatility index, growth index and solvency index. Earnings per share increased from -$0.0049 to $0.0059, EBIT increased 67.52% from -$190.9 to -$62, and operating cash flow increased 15.92% from -$204.1 to -$171.6.

Sell 9/1/2023Upgraded
Bio Essence Corporation (BIOE) was upgraded to E+ from E on 9/1/2023 due to an increase in the solvency index and valuation index. The quick ratio increased from 0 to 0.01, and debt to equity declined from -1.13 to -1.41.

Sell 6/2/2023Upgraded
Bio Essence Corporation (BIOE) was upgraded to E from E- on 6/2/2023 due to a noticeable increase in the total return index, efficiency index and valuation index. Net income increased 16.1% from -$213.1 to -$178.8, and total capital increased 0.41% from $1.38M to $1.39M.

Sell 2/28/2023None
Bio Essence Corporation (BIOE) was downgraded to E- from U on 02/28/2023.